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Abstract: Carbon catabolite repression (CCR) is a common mechanism pathogenic bacteria use to
link central metabolism with virulence factor synthesis. In gram‐positive bacteria, catabolite control
protein A (CcpA) and the histidine‐containing phosphocarrier protein HPr (encoded by ptsH) are
the predominant mediators of CCR. In addition to modulating CcpA activity, HPr is essential for
glucose import via the phosphotransferase system. While the regulatory functions of CcpA in
Staphylococcus aureus are largely known, little is known about the function of HPr in CCR and
infectivity. To address this knowledge gap, ptsH mutants were created in S. aureus that either lack
the open reading frame or harbor a ptsH variant carrying a thymidine to guanosine mutation at
position 136, and the effects of these mutations on growth and metabolism were assessed.
Inactivation of ptsH altered bacterial physiology and decreased the ability of S. aureus to form a
biofilm and cause infections in mice. These data demonstrate that HPr affects central metabolism
and virulence in S. aureus independent of its influence on CcpA regulation.

HPr on Carbon Metabolism and
Virulence in Staphylococcus aureus.
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Carbon catabolite repression (CCR) is a common regulatory mechanism of bacteria
to coordinate central metabolism with available carbon source(s) [1]. By modulating
transcription of genes encoding proteins involved in the import and catabolism of carbon
metabolites, bacterial CCR facilitates the efficient use of available carbon sources [1]. In
pathogenic bacteria, regulators of CCR often affect transcription of virulence factors that
are important for the exploitation of host‐derived nutrient sources [2].
Staphylococcus aureus is a gram‐positive opportunistic pathogen and a frequent cause
of nosocomial infections in which central metabolism and infectivity are linked by
numerous regulatory factors, including the catabolite control proteins A (CcpA) and E
(CcpE), CodY, Rex, RpiRc, and SrrAB [3]. CcpA, a member of the GalR‐LacI repressor
family [4], is thought to be the major factor regulating CCR in S. aureus by binding
catabolite‐responsive element (cre) sequences of target genes [5]. Depending on the cre
sequence location in the promotor region, the binding of CcpA results in either activation
or repression of transcription [6]. Studies using Bacillus megaterium and Streptococcus
pyogenes demonstrated that the binding affinity of CcpA for cre sites is low, but can be
increased drastically by complex formation with the histidine‐containing phosphocarrier
protein (HPr), encoded by ptsH [7,8]. Electrophoretic mobility shift assays suggest this is
also true in S. aureus [6], although CcpA can also bind to cre sites in the absence of HPr
[9]. Activity of HPr is dependent on at least two phosphorylation sites, namely amino
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acids histidine 15 (His‐15) and serine 46 (Ser‐46) [1]. For complex formation with CcpA,
HPr must be phosphorylated on Ser‐46 [7]. This ATP‐requiring process is catalyzed by the
HPr‐kinase/phosphorylase (HPrK/P), which is regulated in a dose‐dependent manner by
the glycolytic intermediate fructose‐1,6‐bisphosphate (FBP) [10]. For this reason, the
amount of Ser‐46 phosphorylated HPr (P‐Ser‐HPr) is closely connected with glycolytic
activity of the cell and the uptake of sugars. Sugar uptake in bacteria is predominantly
mediated by the phosphotransferase system (PTS), consisting of three main components:
HPr, enzyme I (EI), and enzyme II (EII) [11]. In a first step, HPr is phosphorylated at His‐
15 (P‐His‐HPr) by E1, using the glycolytic intermediate phosphoenolpyruvate as the
phosphate donor. The phosphate group is transferred to the substrate by EII, which
translocates and phosphorylates the sugar into the cell at the same time. Activated
glucose, namely glucose 6‐phosphate, then enters glycolysis [12]; hence, HPr connects
glycolytic activity with CCR via its dual role in sugar uptake through the PTS and as an
activator of CcpA [13,14].
Numerous genes have been identified to be regulated on the transcriptional level by
CcpA in S. aureus [15–17]. In addition to genes/operons involved in carbon catabolism, the
synthesis of factors associated with biofilm formation and virulence of S. aureus are also
influenced by CcpA [6,15–21]. Specifically, CcpA promotes transcription of the ica‐operon
and cidA [19], encoding proteins needed for polysaccharide intercellular adhesion (PIA)
synthesis and extracellular DNA release, respectively [22,23]. These observations are
consistent with the fact that deletion of ccpA abrogates biofilm formation under glucose‐
rich conditions. [19]. Furthermore, inactivation of ccpA in S. aureus reduces the formation
of liver and skin abscesses in mouse models of infection [6,24,25]. Taken together, these
observations demonstrate the linkage between CcpA, glucose catabolism, and virulence
in S. aureus; however, the function of HPr remains largely unknown. Here, we characterize
the function of HPr of S. aureus in the context of carbon metabolism, growth kinetics,
biofilm formation, and in vivo infectivity in different murine infection models.
2. Materials and Methods
2.1. Bacterial Strains and Plasmids
The bacterial strains and plasmids used in this study are listed in Table 1. All mutant
strains generated for this study were confirmed by sequencing of the affected region, and
by assessing gene transcription by quantitative real‐time reverse transcriptase PCR (qRT‐
PCR).
2.2. Bacterial Growth Conditions
S. aureus strains were grown in tryptic soy broth (TSB) containing 0.25% (w/v)
glucose (BD, Heidelberg, Germany) or on TSB plates containing 1.5% agar (TSA).
Antibiotics were only used for strain construction and phenotypic selection at the
following concentrations: tetracycline, 2.5 μg/mL; erythromycin, 2.5 μg/mL; kanamycin,
15 μg/mL; and chloramphenicol, 10 μg/mL. Bacteria from overnight cultures were diluted
in pre‐warmed TSB to an optical density at 600 nm (OD600) of 0.05. All bacterial cultures
were incubated at 37 °C and 225 rpm with a flask‐to‐medium ratio of 10:1. Samples for
determination of the OD600, pH, and metabolites were taken every hour. The growth rate
(μ) of S. aureus strains was calculated by the formula (ln OD2–ln OD1)/(t2–t1), with OD1 and
OD2 being the OD calculated from the exponential growth phase at time t1 and t2,
respectively. The generation time of each strain was determined using the formula ln 2/μ.
2.3. Mutant Construction
For the S. aureus ptsH deletion mutants, 1.4‐ and 1.1‐kb fragments (nucleotides
1053472‐1054838 and 1055049‐1056169 of GenBank accession no. AP009351.1,
respectively), containing the flanking regions of the ptsH open reading frame (ORF), were
amplified by PCR from chromosomal DNA of S. aureus strain Newman using primer pairs
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MBH‐94/MBH‐112 and MBH‐113/MBH‐114, respectively (Supplementary Table S1). The
PCR products were digested with KpnI/EcoRI and BamHI/XbaI, respectively, and cloned
together with the EcoRI/BamHI‐digested lox66‐aphAIII‐lox71 resistance cassette obtained
from pBT lox‐aph [26] into KpnI/XbaI‐digested suicide vector pBT [27] to generate plasmid
pBT ptsH KO. Plasmid pBT ptsH KO was propagated in E. coli strain DC10B [28] and
subsequently electroporated directly into S. aureus strain Newman to obtain strain
Newman ΔptsH‐aph, in which nucleotides 8 to 225 of the 267‐bp spanning ptsH ORF were
replaced by the lox66‐aphAIII‐lox71 cassette by allelic replacement. The deletion of ptsH in
Newman ΔptsH‐aph was confirmed by PCR, and the strain was then used as a donor for
transducing the lox66‐aphAIII‐lox71 tagged ptsH deletion into S. aureus strains SA113 and
RN4220. Resistance marker‐free ΔptsH::lox72 derivatives were constructed by treatment
with a Cre recombinase expressed from the temperature‐sensitive vector pRAB1 [29],
which was subsequently removed from the aphIII‐cured derivatives by culturing the
strains at 42 °C.
Table 1. Strains and plasmids used in this study.

Strain

Description 1

S. aureus
Newman
Mouse pathogenic laboratory strain (ATCC 25904)
RN4220
NCTC8325‐4 derivative, acceptor of foreign DNA
SA113
PIA‐dependent biofilm producer (ATCC 35556), agr rsbU
Nm ccpA
MST14; Newman ΔccpA::tet(L); TcR
Nm ptsH
Newman ΔptsH::lox72
Nm ptsH‐aph
Newman ΔptsH::lox66‐aphaIII‐lox71; KanR
Nm ptsH::ptsH
Newman ΔptsH::pBT ptsH; TcR
Nm ptsH *
Newman ΔptsH::lox72 pBTptsH*; TcR
Nm ccpA_ptsH
Newman ΔccpA::tet(L) ΔptsH::lox72; TcR
RN4220 ptsH
RN4220 ΔptsH::lox72
SA113 ccpA
KS66; SA113 ΔccpA::tet(L); TcR
SA113 ptsH
SA113 ΔptsH::lox72
SA113 ptsH::ptsH
SA113 ΔptsH::pBT ptsH; TcR
SA113 ptsH *
SA113 ΔptsH::lox72 pBTptsH*; TcR
SA113 ccpA_ptsH
SA113 ΔccpA::tet(L) ΔptsH::lox72; TcR
E. coli
DH5α
Cloning strain
DC10B
Δdcm in the DH10B background; Dam methylation only
Plasmids
pBT
S. aureus suicide plasmid; tet(L)
pBT derivative harboring lox66‐aphAIII‐lox71; tet(L),
pBT lox‐aph
aphIII
Temperature sensitive E. coli‐S. aureus shuttle plasmid,
pRAB1
expression of cre in staphylococci; cat, bla
pBT derivative harboring a C‐terminal ptsI fragment;
pBT ‘ptsI
tet(L)
pBT ptsH1
pBT derivative harboring a T136G ptsH variant; tet(L)
pBT derivative harboring the genomic regions flanking
pBT ptsH KO
ptsH and lox66‐aphAIII‐lox71 of pBT lox‐aph; aphIII, tet(L)
1

Reference
or Source
[30]
[31]
[32]
[15]
This study
This study
This study
This study
This study
This study
[19]
This study
This study
This study
This study
Invitrogen
[28]
[27]
[26]
[29]
This study
This study
This study

KanR, kanamicin‐resistant; PIA, polyintercellular adhesin; TcR, tetracycline‐resistant.

For the cis‐complementation of the ΔptsH::lox72 mutants, a 1‐kb fragment
(nucleotides 1055996‐1056973 of GenBank accession no. AP009351.1) of the C‐terminal
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region of the ptsI ORF and the annotated terminator region of the ptsHI operon was
amplified by primers MBH‐427/MBH‐428 (Supplementary Table S1), digested with
EcoRI/KpnI and cloned into EcoRI/KpnI‐digested suicide vector pBT [27] to generate
plasmid pBT ‘ptsI. The plasmid was electroporated into S. aureus strain RN4220, and a
tetracycline‐resistant RN4220 derivative that integrated pBT ‘ptsI in its chromosome at the
ptsI locus was used as donor to phage‐transduce the tet(L)‐tagged ptsI allele into Nm
ΔptsH and SA113 ΔptsH, respectively, thereby replacing the ptsH::lox72 deletion with the
ptsI::pBT ‘ptsI genomic region containing a functional ptsHI operon.
For the construction of S. aureus ptsH variants harboring a T to G exchange of
nucleotide 136 of the ptsH ORF (termed ptsH*), 0.6‐kb and 1.1‐kb fragments, containing
either the promoter region of ptsH and the N‐terminal part of the ptsH ORF (nucleotides
1054446‐1054998 of GenBank accession no. AP009351.1) or the C‐terminal part of the ptsH
ORF and an N‐terminal fragment of the ptsI ORF (nucleotides 1054976‐1056121 of
GenBank accession no. AP009351.1) were amplified by PCR from chromosomal DNA of
S. aureus strain Newman using primer pairs MBH‐484/MBH‐485 and MBH‐86/MBH‐20,
respectively (Supplementary Table S1). Primer MBH‐484 contains a non‐complementary
base that introduces a point mutation in the PCR fragment leading to the T136G exchange
of the ptsH ORF. Both PCR products were digested with StyI and subsequently ligated
with T4 DNA‐ligase. The ~1.7‐kb ligation product was gel‐purified, digested with
KpnI/PstI, and cloned into KpnI/PstI‐digested pBT to generate plasmid pBT ptsH1 (Table
1). Presence of the T136G exchange in ptsH* harbored by plasmid pBT ptsH1 was
confirmed by sequencing, the plasmid propagated in E. coli strain DH5α, electroporated
into RN4220 ΔptsH, and selected for tetracycline‐resistance. A tetracycline‐resistant
RN4220 derivative that integrated pBT ptsH1 at the ptsHI locus was used as donor to
transduce the tet(L)‐tagged ptsH* allele into the ΔptsH mutants.
S. aureus double mutants lacking ptsH and ccpA were created by transducing the
tet(L)‐tagged ccpA deletion of MST14 into ΔptsH derivatives.
2.4. RNA Isolation and Purification, cDNA Synthesis and qRT‐PCR
S. aureus strains were cultivated in TSB as described above. Bacterial pellets were
collected after 2 h and 8 h of incubation by centrifugation at 5,000 rpm at 4 °C for 5 min,
and immediately suspended in 100 μL ice‐cold TE‐buffer (10 mM Tris‐HCl, 1 mM EDTA,
pH 8). Bacteria were disrupted, total RNA isolated, transcribed into cDNA, and qRT‐PCRs
carried out as described previously [33] using the primers listed in Supplementary Table
S1. Transcriptional levels of target genes were normalized against the mRNA
concentration of housekeeping gene gyrB according to the 2−ΔCT method.
2.5. Measurement of pH, Glucose, Acetate, and Ammonium in Culture Supernatants
Aliquots (1.5 mL) of bacterial cultures were centrifuged for 2 min at 10,000 g, and
supernatants were removed, pH measured, and stored at −20 °C until further use.
Glucose, acetate, and ammonia concentrations were determined with kits purchased from
R‐Biopharm (Pfungstadt, Germany) and used according to the manufacturer’s directions.
The metabolite concentrations were measured from at least three independent
experiments.
2.6. Biofilm Assays
Biofilm formation under static conditions was assessed as described [19]. Briefly,
overnight cultures were diluted to an OD600 of 0.05 in fresh TSB medium supplemented
with glucose to a final concentration of 0.75 % (w/v), and 200 μl of the cell suspension was
used per well to inoculate sterile, flat‐bottom 96‐well polystyrene microtiter plates (BD).
After incubation for 24 h at 37 °C without shaking, the plate wells were washed twice with
phosphate‐buffered saline (pH 7.2) and dried in an inverted position. Adherent cells were
safranin‐stained (30 sec with 0.1% safranin; Merck, Darmstadt, Germany) and the
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absorbance of stained biofilms was measured at 490 nm after resolving the stain with 100
μL 30 % (v/v) acetic acid, using a microtiter plate reader (Victor2 1420 Multilabel Counter;
Perkin Elmer, Rodgau, Germany).
Biofilm formation under flow conditions was performed as described [34], with
minor modifications: Bacteria from overnight cultures were diluted to an OD600 of 0.05 in
fresh TSB medium supplemented with glucose to a total concentration of 0.75 % (w/v) and
cultivated for 2 h at 37 °C with shaking at 150 rpm. Flow cells (Stovall Life Science) were
filled with pre‐warmed TSB medium supplemented with glucose to a total concentration
of 0.75 % (w/v), attached to a peristaltic pump (Ismatec REGLO Digital; Postnova,
Landsberg am Lech, Germany) and inoculated with 0.5 mL of the bacterial cultures. Thirty
minutes after inoculation, the flowrate was set to 0.5 mL/min and chamber. Biofilm
formation was visually documented at different times.
For the assessment of biofilm formation on medical devices under dynamic
conditions, peripheral venous catheter (PVC, Venflon Pro Safety 18 G; BD) fragments of 1
cm length were placed into reaction tubes filled with 1 mL of TSB and inoculated with 5 ×
105 CFU of TSB‐washed bacterial cells obtained from exponential growth phase
(inoculation of TSB from overnight cultures to an OD600 of 0.05 and incubation for 2.5 h at
37 °C and 225 rpm). The PVC fragments were incubated under non‐nutrient limited
conditions for five days at 37 °C and 150 rpm, and the media were replaced with fresh
media every 24 h. PVC fragments were placed five days post inoculation into fresh
reaction tubes filled with 1 mL of TSB, biofilms were detached from the catheter surface
and resolved by sonification (50 watt for 5 min) followed by 1 min of vortexing. CFU rates
and biomasses of resolved biofilms and culture supernatants at day five post inoculation
were determined by plate counting and OD600 measurements, respectively.
2.7. Primary Attachment Assay on Polystyrene
The primary attachment of bacterial cells to polystyrene surfaces was performed as
described [35], with minor modifications. Briefly, bacteria from the exponential growth
phase (inoculation of TSB from overnight cultures to an OD600 of 0.05 and incubation for
2.5 h at 37 °C and 225 rpm) were diluted in TSB to 3000 CFU/mL. 100 μL of the bacterial
inoculum was poured onto polystyrene petri dishes (Sarstedt, Nümbrecht, Germany) and
incubated under static conditions at 37 °C for 30 min. After incubation, petri dishes were
rinsed gently three times with 5 mL of sterile PBS (pH 7.5), and subsequently covered with
15 mL of TSB containing 0.8 % agar maintained at 48 °C. Plates were incubated at 37°C for
24 h. Bacterial attachment to polystyrene was defined as the number of CFU remaining
on the petri dish bottom after washing compared to the number of CFU remaining on the
petri dish bottom without washing.
2.8. Animal Models
All animal experiments were performed with approval of the local State Review
Board of Saarland, Germany (project identification codes 60/2015 [approved 21.12.2015],
and 34/2017 [approved 09.11.2017]), and conducted following the national and European
guidelines for the ethical and human treatment of animals. PBS‐washed bacterial cells
obtained from exponential growth phase cultures were used as inoculum.
For the murine abscess model, infection of animals was carried out as described [33],
with minor modifications; specifically, 8‐ to 12‐ week‐old female C57BL/6N mice (Charles
River, Sulzfeld, Germany) were anesthetized by isoflurane inhalation (3.5%; Baxter,
Unterschleißheim, Germany) and 100 μl bacterial suspension containing 5 × 107 CFU were
administered intravenously by retro bulbar injection. Immediately after infection, animals
were treated with a single dose of carprofen (5 mg/kg; Zoetis, Berlin, Germany). Behavior
and weight of mice was monitored daily, and four days post‐infection, mice were
sacrificed, and livers and kidneys were removed. The bacterial loads in liver and kidney
tissues were determined by homogenization of weight‐adjusted organs in PBS (pH 7.4),
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followed by serial dilutions on sheep blood agar plates and plate counting after 24 h
incubation at 37 °C.
For the S. aureus based murine foreign body infection model, implantation of catheter
fragments and infection of animals was carried out as described [36], with minor
modifications: 8‐ to 12‐ week‐old female C57BL/6N mice (Charles River) were
anesthetized by intraperitoneal injection of 0.05 mg/kg body weight fentanyl (Hexal,
Holzkirchen, Germany), 5 mg/kg midazolam (Hameln Pharma Plus, Hameln, Germany)
and 0.5 mg/kg medetomidine (Orion Pharma, Hamburg, Germany). After treatment with
a dose of carprofen (5 mg/kg, Zoetis), the animals were shaved with an animal trimmer
(BBraun, Melsungen, Germany) and depilated with asid‐med hair removal cream (Asid
Bonz, Herrenberg, Germany) on both flanks. The depilated skin was disinfected with
ethanol (70 %) and 1 cm catheter fragments (PVC, 14G, Sarstedt) were implanted
subcutaneously and inoculated with 1 × 104 CFU of the respective S. aureus strains.
Wounds were closed with staples (Fine Science Tools, Heidelberg, Germany) and
anesthesia was antagonized with 1.2 mg/kg body weight naloxone (Inresa, Freiburg im
Breisgau, Germany), 0.5 mg/kg flumazenil (Inresa) and 2.5 mg/kg atipamezole (Orion
Pharma). Behavior and weight of the animals was monitored daily. Ten days post
infection, animals were sacrificed, edema sizes were measured and photo documented,
and catheter fragments with surrounding tissue were harvested for microbial analyses.
Excised tissues were homogenized in 1 mL TSB with a hand disperser (POLYTRON PT
1200 E; Kinematica, Eschbach, Germany), and biofilms were detached from the PVC
fragments and resolved by sonification (50 watt for 5 min) followed by vortexing (1 min).
CFU rates in tissue and of biofilm formed on the catheter were determined by plating
serial dilutions on sheep blood agar plates and plate counting after 24 h of incubation at
37 °C.
2.9. Statistical Analyses
The statistical significance of changes between groups was assessed by one‐way
ANOVA followed by Holm‐Sidak’s post‐hoc tests for experiments containing ≥ 5
biological replicates using the GraphPad software package Prism 6.01 (San Diego, CA
92108, USA). p values < 0.05 were considered statistically significant.
3. Results and Discussion
3.1. Growth, pH Characteristics, and Metabolite Profiles Differ between ptsH and ccpA Mutants
To determine if inactivation of ptsH in S. aureus leads to changes in growth and
carbon catabolism, mutants were constructed in the S. aureus laboratory strain Newman
(Table 1) and growth and physiology were assessed (Figure 1). In detail, a mutant lacking
ptsH (ΔptsH) was constructed and cis‐complemented (ptsH::ptsH), and a ΔccpA ptsH
double mutant was created (ccpA_ptsH). In addition, a ptsH mutant harboring a point
mutation in the ptsH gene (T136G) leading to the substitution of serine to alanine at
position 46 of HPr (HPr‐S46A) was constructed (ptsH*). The phosphorylation at this amino
acid represents a known prerequisite for HPr to activate CcpA in other gram‐positive
bacteria (14), while its activity in the phosphotransferase uptake system (PTS) should be
unaffected. The parental strain Newman and the cis‐complemented ptsH derivative
displayed similar growth characteristics and comparable generation times, respectively.
In contrast, all ptsH mutants (ptsH, ccpA_ptsH, and ptsH*) had reduced growth rates in the
exponential (1–3 h) and the transition phase (4–6 h) relative to the wild type (Figure 1 and
Table 2). Interestingly, the growth rate of the isogenic ccpA deletion mutant was only
slightly diminished relative to that of strain Newman (Figure 1 and Table 2), and differed
significantly from the wild type only during the transition phase. After 12 h of cultivation,
growth yields were comparable for all strains (Figure 1b), suggesting that neither the lack
of CcpA nor HPr has a clear long‐term effect on biomass production of S. aureus cultured
in rich medium. This is in line with earlier findings regarding CcpA [15].
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Figure 1. Impact of ptsH and/or ccpA on growth and pH profiles of S. aureus TSB cultures. Bacteria
were inoculated to an OD600 of 0.05 in TSB and cultured aerobically at 37 °C and 225 rpm. OD600 (a,b)
and pH measurements (c) of the culture media were determined hourly. Symbols represent: strains
Newman (black symbols), Nm ptsH (white symbols), Nm ptsH::ptsH (grey symbols), Nm ptsH*
(yellow symbols), Nm ccpA (red symbols), and Nm ccpA_ptsH (blue symbols). The results are the
mean ± SD of at least five independent experiments. (b) OD600 readings of the cell cultures at 2, 5,
and 12 h of growth, respectively. The data are presented as box and whisker plot showing the
interquartile range (25–75 %, box), the median (horizontal line), and the standard deviation (bars)
of 5–6 independent experiments. **, p < 0.01 (one‐way ANOVA and Holm‐Sidak’s multiple
comparison test. Only differences between Newman and mutants are shown).
Table 2. Generation time of S. aureus strains cultivated in TSB under aerobic conditions.

Strain
Newman
Nm ptsH
Nm ptsH::ptsH
Nm ptsH *
Nm ccpA
Nm ccpA_ptsH

Generation Time (min) 1
28.6 ± 1.9
34.8 ± 1.6
27.8 ± 1.3
33.3 ± 1.4
30.0 ± 1.3
34.3 ± 1.0

P Value 2
< 0.01
0.34
< 0.01
0.19
< 0.01

1 Data are presented as mean ± SD (n = 6). 2 p values were determined by one‐way ANOVA and
Holm‐Sidak’s multiple comparison test.

To assess the bacterial acid production during growth, the pH of culture supernatants
was measured over time (Figure 1c). The pH of culture supernatants from wild type and
cis‐complemented ptsH mutant cultures were similar. In contrast, pH values of culture
supernatants from the ptsH and ccpA_ptsH deletion mutants indicated that little acid was
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produced during growth. The pH profiles of the ptsH * and ccpA mutant cultures were
between these two extremes but indicated that acidic end‐products were produced and
consumed during growth. Taken together, these data indicate that inactivation of ptsH, or
interference with HPr phosphorylation, delays growth and medium acidification to a
greater extent than does deletion of ccpA. In addition, the small differences in
physiological parameters (i.e., growth and pH kinetics) between the ptsH and the
ccpA_ptsH mutants and between the ccpA and ptsH* mutants indicate additional, CcpA‐
independent functions of HPr.
To get an idea about the metabolic processes that are active in Newman wild type
and mutant cells cultured in TSB, the concentrations of glucose, acetate, and ammonia
were determined in culture supernatants over time (Figure 2). Strain Newman and the cis‐
complemented ptsH mutant (ptsH::ptsH) depleted all available glucose in the medium
within the first 5 h of cultivation (Figure 2a). In contrast, glucose depletion in ptsH and
ccpA_ptsH mutant cultures was severely delayed, and low concentrations of glucose
were still detectable in culture supernatants even after 10 h of growth. In ccpA and ptsH*
mutant cultures, glucose levels decreased slower than in wild type cultures, and no
glucose was detectable after 7 h of growth (Figure 2a).

Figure 2. Impact of ptsH and/or ccpA on glucose consumption, acetate and ammonia production of S. aureus Newman
during in vitro growth. S. aureus strains Newman (black symbols), Nm ptsH (white symbols), Nm ptsH::ptsH (grey
symbols), Nm ptsH* (yellow symbols), Nm ccpA (red symbols), and Nm ccpA_ptsH (blue symbols) were cultivated in TSB,
and glucose (a), acetate (b), and ammonia (c) concentrations in culture supernatants were determined hourly. Results are
presented as the average and standard deviation of at least three independent experiments.

When S. aureus is cultured aerobically in a glucose‐containing medium, cells produce
and secrete acetate as long as glucose is available [37]. Consistent with this fact, increasing
acetate concentrations in the culture supernatants were observed during the first 5–6 h of
growth for all strains (Figure 2b). However, while all strains accumulated acetate in the
medium, the maximum concentrations differed; specifically, the wild type and the cis‐
complemented ptsH derivative accumulated up to 22 mM of acetate. In contrast,
supernatants from ptsH and ccpA_ptsH mutant strain cultures had approximately one‐
third of the concentration of that from the wild type strain. Similar to that seen in the pH
profiles (Figure 1c), the acetate profiles of ptsH* and ccpA mutant cultures centered in
between those two extremes (Figure 2b). At 7–8 h post inoculation, acetate levels
decreased in the supernatants of all cultures, irrespective of the fact that glucose was
present in ptsH and ccpA_ptsH mutant cultures (Figure 2a).
S. aureus also utilizes amino acids as carbon sources for growth, a process that
requires deamination of the amino acids, resulting in the secretion of ammonia into the
culture supernatant [20]. The uptake and catabolism of amino acids in S. aureus is subject
to CCR [20]. While glucose was present in the medium, ammonia levels remained low in
the wild type and ptsH::ptsH culture supernatants, followed by a steady increase in the
ammonia concentrations (Figure 2c). In contrast, cultures of strains Nm ptsH and Nm
ccpA_ptsH began to accumulate ammonia beginning at 3 h of cultivation. Interestingly,
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the ammonia concentration in the supernatant of the ccpA mutant closely resembled that
of the ptsH deletion mutants, while the ptsH* mutant resembled the late induction of the
wild type strain (Figure 2c).
Taken together, these data show that the inactivation of ptsH or ccpA results in
distinct differences in glucose consumption, acetate accumulation and reutilization, and
ammonia secretion in S. aureus. Furthermore, the exchange of an amino acid critical for
the interaction of HPr with CcpA in the ptsH* mutant resulted in metabolite profiles (i.e.,
glucose and acetate) comparable to the ccpA mutant, while some alterations in the
growth profile, generation time, and ammonia secretion were observed. Importantly, after
12 h of growth, the biomass of S. aureus Newman was independent of ccpA and ptsH,
suggesting that S. aureus has other means to utilize carbon sources in the growth medium.
Specifically, ptsH mutants were able to utilize glucose from the growth medium—
although much slower than the wild type—demonstrating that S. aureus can transport
glucose independent of the group translocation PTS [38]. A likely compensatory
transporter would be one of the many ATP binding cassette transporters identified in S.
aureus [39].
3.2. Inactivation of ptsH and/or ccpA Alters Transcription of TCA Cycle and Virulence Factor
Genes
CcpA is known to affect transcription of a large number of central carbon metabolism
and virulence genes [15–17]. For this reason, the effect of ptsH deletion on transcription of
genes regulated by CcpA such as citB (encoding the TCA cycle key enzyme aconitase),
pckA (encoding the gluconeogenesis key enzyme phosphoenolpyruvate carboxykinase),
and hla (encoding ‐hemolysin) was assessed. Specifically, mRNA levels were determined
in cells from the exponential (i.e., 2 h) and post‐exponential growth phases (i.e., 8 h) by
qRT‐PCR (Figure 3).

Figure 3. Effect of ptsH and/or ccpA mutations on the transcription of S. aureus. Newman wild type and mutant cells were
cultured aerobically in TSB, as outlined in Materials and Methods. Cells were harvested at the time points indicated, total
RNAs isolated, and qRT‐PCRs performed for citB (a), pckA (b), and hla (c). Transcripts were quantified in reference to the
transcription of gyrase B. Data are presented as mean + SD of five biological replicates. *, p < 0.05; **, p < 0.01 (one‐way
ANOVA and Holm‐Sidak’s multiple comparison test; only differences between Newman and mutants are shown).

Consistent with our previous observation that S. aureus transcription of citB and pckA
is repressed by CcpA when cultivated with glucose [16], deletion of ccpA significantly
increased the level of citB and pckA mRNA in exponential growth phase cells relative to
wild type cells (Figures 3a and b). As expected, in the post‐exponential growth phase,
comparable citB and pckA transcript levels were observed in the ccpA mutant and the
wild type. Similar to the ccpA mutant, exponential growth phase cells of the ptsH mutants
(ptsH, ptsH*, and ccpA_ptsH) had comparable citB and pckA mRNA levels, while the cis‐
complemented ptsH derivative (ptsH::ptsH) had citB and pckA transcript levels comparable
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to the wild type strain. In contrast to exponential growth phase cultures, all three ptsH
mutants produced significantly lower levels of pckA mRNA than the wild type at 8 h,
suggesting that pckA transcription is affected by HPr at later growth stages in a way that
is independent of CcpA. This differed from the results for citB in which all ptsH mutants
(ptsH, ptsH*, and ccpA_ptsH) had comparable transcript levels to that of the ccpA
mutant and the wild type after 8 h of growth. The fact that the ptsH* mutant produced
pckA transcript levels similar to the ptsH mutant, but not similar to the ccpA mutant
suggests that HPr phosphorylated at serine 46 acts in part independent of CcpA. This
observation is consistent with that found in other gram‐positive bacteria, where the serine
46‐phosphorylated HPr exerted effects on CCR via CcpA and inducer exclusion [40].
However, it cannot be excluded that differences in pckA transcription between the ptsH*
and ccpA mutants are due to differences in protein stability. The reason why protein
stability cannot be excluded is because phosphorylation of the B. subtilis HPr homolog at
Ser‐46 stabilized the protein [41], while a serine to alanine exchange of Ser‐46 in the E. coli
HPr homolog was found to decrease the stability of the protein [42].
CcpA represses transcription of hla during the exponential growth phase when
bacteria are cultured in presence of glucose [15,16]. Similarly, levels of hla mRNA from
the exponentially growing ccpA mutant and all ptsH mutants (Figure 3c) were de‐
repressed, while the cis‐complemented ptsH deletion mutant produced hla transcript
levels that were comparable to the wild type. During the post‐exponential growth phase,
only the hla transcript levels of the ptsH and the ccpA_ptsH double mutant were
significantly increased (Figure 3c), suggesting that HPr affects expression of ‐hemolysin
in a CcpA‐dependent and ‐independent manner. Taken together, these data suggest that
exponential growth phase S. aureus was cultured in the presence of glucose, HPr affects
the transcription primarily via activation of CcpA, while in the post‐exponential growth
phase cells of S. aureus, HPr is likely to affect gene transcription by CcpA‐independent
mechanism(s).
3.3. Impact of ptsH Deletion on Biofilm Formation of S. aureus SA113
CcpA is important for polysaccharide intercellular adhesin (PIA)‐dependent biofilm
formation by staphylococci under glucose‐rich in vitro conditions [19,24,43]. The
importance of HPr on sugar import and gene regulation suggests that HPr might influence
biofilm formation of S. aureus. Strain Newman is a weak biofilm producer in glucose‐rich
medium under in vitro conditions [34], hence we transduced the ptsH mutations into S.
aureus strain SA113, which forms a strong biofilm under these conditions [19,22]. The
ability of SA113 mutant strains were analyzed using a semi‐quantitative static biofilm
assay (Figure 4a) and in biofilm flow cells (Figure 4b).
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Figure 4. Mutations of ptsH affect biofilm formation of S. aureus under static and flow conditions. (a) Biofilm growth of S.
aureus strains in a static 96‐well microplate assay. The data show the mean + SD of five biological replicates. (b) Flow cell
chambers were inoculated with S. aureus strains as indicated, allowed to attach to the surfaces for 30 min, and incubated
under constant flow for 24 h. The results shown are representative of two independent experiments. (c) Effect of the ptsH
mutation on the transcription of icaA in S. aureus strain SA113. Cells of SA113, the ptsH mutant, and the cis‐complemented
ptsH::ptsH derivative were cultured aerobically in TSB. After 2 h of growth, cells were harvested, total RNAs isolated, and
qRT‐PCRs performed for icaA. Transcripts were quantified in reference to gyrase B mRNA. Data are presented as mean +
SD of five biological replicates. **, p < 0.01 (one‐way ANOVA and Holm‐Sidak’s multiple comparison test; only differences
between SA113 and mutants are shown).

Under static conditions, the ptsH and ccpA_ptsH mutants of SA113 displayed
drastic decreases in their biofilm formation capacities on polystyrene surfaces, whereas
the cis‐complemented derivative (ptsH::ptsH) formed biofilms that were comparable to
the ones seen with the wild type (Figure 4a). Deletion of ccpA or the S46A mutation of HPr
in SA113 (ptsH*) also significantly reduced biofilm formation, however, not to the extent
seen with the ptsH mutant, supporting our hypothesis that a functional PTS is important
for S. aureus to form a biofilm in this type of assay. In the flow chamber assay, the ptsH
mutant failed to produce a clear biofilm within the microchannel after 24 h of constant
flow, while both, the wild type and the cis‐complemented ptsH derivative, almost
completely filled the microchannel with biomass (Figure 4b), suggesting that HPr is also
important for biofilm formation under shear flow. To exclude that the latter phenotype
was caused by a decreased capacity of the ptsH mutant to attach to the microchannel
surface, the primary attachment capacities of the strains were determined. Here, no clear
differences in attachment towards polystyrene surfaces were obtained for the strain
triplet, suggesting that the observed lack of biofilm formation of the SA113 ptsH mutant
is likely due to a deficiency in biofilm maturation. To determine whether this effect might
be due to a decreased capacity of the mutant to produce PIA, we assayed the transcription
of icaA, which is part of the icaADBC polycistronic mRNA that encodes proteins needed
for PIA synthesis [22]. Consistent with the reduced ability of the SA113 ptsH mutant to
form a biofilm under static and flow conditions, we observed significantly decreased
levels of icaA transcripts in the ptsH deletion mutant relative to the wild type and the cis‐
complemented mutant (Figure 4c). Together, these data suggest that HPr, in part,
promotes biofilm formation of S. aureus by enhancing the expression of the PIA synthesis
machinery.
In a third biofilm assay intended to resemble the in vivo situation more closely, we
studied the ability of SA113 and its derivatives to form biofilms on peripheral venous
catheter (PVC) fragments under non‐nutrient limited conditions (Figure 5).
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Figure 5. Inactivation of ptsH and/or ccpA reduces the biofilm formation capacity of S. aureus on medical devices. (a) Images
of S. aureus‐loaded catheter fragments at day 5 post inoculation (6.3‐fold magnification). The results are representative of
three independent experiments. (b,c) Colony forming units (CFU) and total biomass of detached biofilms were determined
by plate counting (b) and measuring the OD600 of the TSB solutions (c). The data are presented as box and whisker plot
showing the interquartile range (25–75 %, box), the median (horizontal line), and the standard deviation (bars) of nine
independent experiments. **, p < 0.01 (one‐way ANOVA and Holm‐Sidak’s multiple comparison test; only differences
between SA113 and mutants are shown).

Using this assay, a strong biofilm was macroscopically detectable on catheter
fragments inoculated with the wild type or the cis‐complemented ptsH derivative at 5
days post inoculation (Figure 5a). In contrast, on catheter fragments inoculated with either
the ptsH mutant, the ccpA mutant, the ptsH* mutant, or the ccpA_ptsH double mutant,
almost no biofilm was visible. These observations were further supported by CFU and
OD600 determinations of TSB solutions harboring the detached biofilms (Figures 5b,c). A
significant reduction in viable bacteria (~1 log) was observed on all fragments inoculated
with mutants when compared to the wild type inoculated fragments (Figure 5b). Similar
to the CFU data, the OD600 values were approximately 10‐fold lower in the detached
biofilms formed by the mutants (Figure 5c), suggesting that ptsH and ccpA deletions elicit
rather comparable effects on the biofilm forming capacity of S. aureus on PVC surfaces
under non‐nutrient limited conditions.
3.4. HPr Contributes to Infectivity and Biofilm Formation of S. aureus SA113 in a Murine
Foreign Body Infection Model
CcpA is not required for biofilm formation of S. aureus and S. epidermidis on
implanted catheter fragments in normoglycemic mice [24,43], but this did not address the
function of HPr in vivo. In order to address this question, the ability of strains SA113, the
ptsH mutant, and the cis‐complemented ptsH derivative to form biofilms on implanted
catheter fragments was assessed in the murine foreign body infection model [36] with
normoglycemic mice (Figure 6).

Figure 6. Inactivation of ptsH reduces the infectivity of S. aureus SA113 in a murine foreign body
infection model. Catheter fragments were implanted subcutaneously into the back of
normoglycemic mice and inoculated with cells of S. aureus strains SA113 (black symbols), its ptsH
deletion mutant (white symbols), and the cis‐complemented ptsH mutant (grey symbols),
respectively (n = eight animals per group). Ten days post infection, animals were euthanized, edema
sizes around the implanted catheters were measured (a), and the catheters and surrounding tissues
were explanted. Bacterial loads from catheter detached biofilms (b) and in surrounding tissue
homogenates (c) were determined by CFU counting. The data represent the values of every
individual animal (symbols) and the median (horizontal line). **, p < 0.01 (one‐way ANOVA and
Holm‐Sidak’s multiple comparison test).
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Mice challenged with the ΔptsH mutant displayed a clear reduction in edema sizes
around the implanted catheter fragments (Figure 6a) and a small but significant reduction
(~2‐fold) in detached bacteria (Figure 6b), when compared to animals infected with wild
type bacteria or the cis‐complemented ptsH derivative. In contrast, no significant
differences in bacterial loads of tissues surrounding the catheter fragments were obtained
(Figure 6c). These findings suggest that HPr, unlike CcpA, has a small but important
function on the biofilm formation capacity of PIA producing S. aureus in normoglycemic
mice. This difference is probably due to a reduced sugar uptake capacity of the ptsH
mutant, which might interfere with the enhanced carbon and energy demand of S. aureus
during biofilm maturation.
3.5. HPr and CcpA Are Both Required for Full Infectivity of S. aureus in a Murine Liver Abscess
Model
The formation of liver abscesses is one of the clinical manifestations caused by S.
aureus in which CcpA exerts a strong effect on disease progression in normoglycemic mice
[6]. To determine how P‐Ser‐HPr affects infectivity of S. aureus in a murine liver abscess
model, the bacterial loads in livers four days post infection were assessed (Figure 7).

Figure 7. Inactivation of ptsH and/or ccpA results in decreased bacterial burden of S. aureus Newman
in a murine abscess model. C57BL/6N mice were infected retro bulbar with 5 × 107 CFU of S. aureus
strains Newman (black symbols), its ΔptsH (white symbols) and ΔccpA (red symbols) mutants, the
ptsH* mutant (yellow symbols), the ΔccpA_ptsH double mutant (blue symbols), and the cis‐
complemented ptsH derivative (grey symbols), respectively. Bacterial loads in liver tissue
homogenates were determined four days post infection. The data display the median (horizontal
lines) and individual values of every animal (dots; n = 8–10 animals per group). **, p < 0.01 (one‐way
ANOVA and Holm‐Sidak’s multiple comparison test; only differences between Newman and
mutants are shown).

Consistent with previous observations [6,24], we observed a nearly 3 log reduction
in bacterial loads in liver tissue of C57BL/6 mice challenged with the ccpA mutant bacteria
(median 2.2 × 105 CFU/g tissue) relative to mice infected with the wild type strain (median
7.6 × 107 CFU/g tissue). Importantly, a greater reduction in CFU/g liver was observed (~4
log; median 1.4 × 104 CFU/g tissue), when mice were challenged with the ptsH mutant.
Infection of mice with the cis‐complemented ptsH derivative resulted in a bacterial burden
in the liver (median 4.2 × 107 CFU/g tissue) comparable to that seen in wild type infected
mice, demonstrating that the decreased CFU rates determined in liver tissues of ptsH
infected mice were due to the lack of HPr. Notably, mice challenged with the ptsH* mutant
carrying the S46A exchange in HPr also caused an almost ~4 log reduction in bacterial
loads in liver tissue (median 2.1 × 104 CFU/g tissue), suggesting that both, the deletion of
ptsH and a mutation of serine 46 of HPr, alter the virulence of S. aureus in this murine
infection model in a CcpA‐independent manner. The lowest CFU rates in liver tissues
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were observed when mice were challenged with the ccpA_ptsH double mutant (median
4.8 × 103 CFU/g tissue), suggesting that CcpA might also exert some effects on virulence
of S. aureus in this infection model independently of HPr.
4. Conclusions
Central carbon metabolism and virulence factor synthesis are tightly linked in S.
aureus and controlled by several transcription factors [3]. Notably, CcpA is the only
transcription factor known to enhance infectivity of S. aureus [6,24,25], while other
regulators such as CcpE, CodY, and RpiRc are thought to attenuate rather than to promote
infectivity of this bacterium in mice [33,44–47]. We show here that HPr contributes
positively to infectivity of S. aureus in mice, presumably by affecting central carbon
metabolism and virulence factor synthesis in a CcpA‐dependent and ‐independent
manner. These effects are likely mediated through changes in sugar transport and carbon
metabolization that alter biofilm formation [24]. It is also possible that HPr in S. aureus
acts like the HPr homolog of E. coli to modulate quorum sensing by interacting with
autoinducer‐2 (AI‐2) modifying factors [48]. Given the importance of HPr on biofilm
formation and virulence in S. aureus, this phosphocarrier protein could be a promising
drug target for the development of novel anti‐staphylococcal compounds.
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Supplementary Table 1: Primers used in this study.
Primer
Cloning primer
MBH20
MBH86
MBH94
MBH112
MBH113
MBH114
MBH427
MBH428

Direction

MBH484

Rev.

MBH485

For.

gtcggtacCTCCACCTATATCTAAAGTACG
GGTGTTATGAGCCTTGGTG
ctcgaaTTCCATAATTACATTTCTCCTTCG
gtcggtACCTTGAAGATGGTTTGATGAC
gtcggatCCATTCAAGCAATCAGTGATGTC
ggatctAGAATGGATTCATTTCTTCAGGC
gtcgaattCTGAGTTTTTATATATGGGTCGTG
gtcggtacCTACATTTTGTTAATGACACATAGTTG
CCAACACCAAGGCTCATAACACCCATGATTGcTTTTAAGT
TTACTTTCTTACC
GAATTATGTCTGCAGCAGCAATTCAAGGTAGTC

For.
Rev.
For.
Rev.
For.
Rev.
For.
Rev.
For.
Rev.

CAAGATCATCAAGTGCCTATTCGT
CGTGATTACCACGTCTTGAACC
GACTGATGCCGATGTGGA
AACGGTGGCTGTGCAATA
AACCCGGTATATGGCAATCAACT
CTGCTGCTTTCATAGAGCCATTT
CTGGCGCAGTCAATACTATTTCGGGTGTCT
GACCTCCCAATGTTTCTGGAACCAACATCC
CACGGCTGGAATAAAAACGG
TGCATAGCAGCCACCTTCG

qRT-PCR primer
citB
citB
gyrB
gyrB
hla
hla
icaA
icaA
pckA
pckA

Rev
For.
Rev.
For.
For.
Rev.
For.
Rev.

Sequence (5’-3’) 1

Small letters represent nucleotides that do not fit with the target sequence. Restriction sites used for
cloning are underlined.
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